Search Ontology:
ChEBI

alogliptin benzoate

Term ID
CHEBI:72324
Synonyms
  • (3R)-1-[3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl]piperidin-3-aminium benzoate
  • 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile benzoate
  • 6-((3R)-3-aminopiperidin-1-yl)-1-(2-cyanobenzyl)-3-methylpyrimidin-2,4(1H,3H)-dione monobenzoate
  • alogliptin monobenzoate
  • Nesina
  • SYR 322
  • SYR-322
Definition
A benzoate salt obtained by combining equimolar amounts of alogliptin and benzoic acid. Used for treatment of type 2 diabetes.
References
  • cas:850649-62-6
  • kegg.drug:D06553
  • patent:EP1586571
  • patent:EP1970063
  • patent:US2007066635
  • patent:WO2010109468
  • patent:WO2011141903
  • pubmed:18499100
  • pubmed:19427871
  • pubmed:19455266
  • pubmed:20883057
  • pubmed:21233588
  • pubmed:21431099
  • pubmed:22296609
  • pubmed:22512582
  • reaxys:12413070
  • wikipedia.en:Alogliptin
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from alogliptin benzoate
Phenotype where environments contain alogliptin benzoate
Phenotype modified by environments containing alogliptin benzoate
Phenotype affecting alogliptin benzoate
Human Disease Model